英文别名:
Ozagrel sodium;SODIUM OZAGREL;4-(1h-imidazol-1-ylmethyl)cinnamic acid sodium salt;OZAGREL SODIUM CP;OzagrelSodiumC13H11N2Nao2;Sodium 3-(4-((1H-imidazol-1-yl)methyl)phenyl)acrylate;Ozagrel (sodiuM salt);sodium,3-[4-(imidazol-1-ylmethyl)phenyl]prop-2-enoate;OKY-046 sodium;OZAGREL SODIUM CP;Ozagrel sodium [WHO-DD];OKY-046 sodium;OKY 046 sodium;OKY046 sodium;F85114;EX-A5745;Sodium(E)-3-(4-((1H-imidazol-1-yl)methyl)phenyl)acrylate;sodium;(E)-3-[4-(imidazol-1-ylmethyl)phenyl]prop-2-enoate;D01684;HY-B0428A;2-Propenoic acid, 3-[4-(1H-imidazol-1-ylmethyl)phenyl]-, sodium salt (1:1);4X5577N3ET;AMY3367;CCG-266963;AKOS015895382;2-Propenoic acid, 3-(4-(1H-imidazol-1-ylmethyl)phenyl)-, sodium salt, (E)-;Xanbon;CS-3808;XanbonS;sodium 3-{4-[(1H-imidazol-1-yl)methyl]phenyl}prop-2-enoate;130952-46-4;AS-12150;KW-01;189224-26-8;DTXSID50172327;AKOS015967214;A912378;Ozagrel sodium (JP17);NCNYJCOBUTXCBR-IPZCTEOASA-M;Ozagrel sodium [JAN:WHO-DD];189224-26-8 (sodium);Q27260625;BCP12393;UNII-4X5577N3ET;Ozagrel sodium salt [MI];2-Propenoic acid, 3-(4-(1H-imidazol-1-ylmethyl)phenyl)-, sodium salt (1:1), (2E)-;AKOS025149474;Ozagrel (sodium);Ozapen (TN);2-Propenoic acid, 3-(4-(1H-imidazol-1-ylmethyl)phenyl)-, sodium salt, (2E)-;AC-15516;SCHEMBL3093220;Ozagrel sodium [JAN];Athrombone;Cataclot;Sodium (E)-3-(4-((1H-imidazol-1-yl)methyl)phenyl)acrylate;Kadenin;HMS3887A15;Monosodium (2E)-3-[4-(1H-imidazol-1-ylmethyl)phenyl]prop-2-enoate;Ozagrel sodium (JP18);Ozapen;Monosodium (2E)-3-(4-(1H-imidazol-1-ylmethyl)phenyl)prop-2-enoate;2-Propenoic acid, 3-[4-(1H-imidazol-1-ylmethyl)phenyl]-, sodium salt,(2E)-;OZAGREL SODIUM SALT;DTXCID5094818;
Inchi:
1S/C13H12N2O2.Na/c16-13(17)6-5-11-1-3-12(4-2-11)9-15-8-7-14-10-15;/h1-8,10H,9H2,(H,16,17);/q;+1/p-1/b6-5+;